Table 1

Plasma HPV DNA in tumor, Clinical staging, and treatment outcome of 50 HPV associated CC patients


Total
 Plasma HPV DNA






Positive
Negative
Cervical Cancer patient
 50
 6
44
Agea





<50
 25
 3
22

>50
 25
 3
22
HPV type





Ub
 4
 0
4

16
 28
 2
26

18
 16
 4
12

33
 2
 0
2
Stage





IB
 2
 0
2

IIB
 17
 3
14

IIIB
 28
 0
28

IVB
 1
 1
0

Rc
 2
 2
0
IIB response to radiotherapy




PRd
 3
 2
1

CRe
 15
 1
13
IIB clinical outcome within



one year after complete



treatment



Rc
6
 2
4
NEDf
5
 0
5
Metastases




Positive
 3
 3
 P = 0001
 0

Negative
 47
 3
 RR = 15.67
 44
Histopathology type




Squamous
 42
 5
37

Adenomatous
 8
 1
7

a<50 and >50 age less than 50, and above 50, respectively; b U, unknown; c R, recurrence: dPR, partial response; e CR, complete response; f NED, no evidence of disease

Pornthanakasem et al. BMC Cancer 2001 1:2   doi:10.1186/1471-2407-1-2